Meros Equity
Personal Account
Atea Pharmaceuticals
IPO AVIR.NASDAQ Past

Atea Pharmaceuticals

Pharmaceuticals

Company website
Ticker

AVIR.NASDAQ

Market

us

Foundation year

2014

Close date

11/10/2020

IPO date

10/29/2020

Placement price

$24

Profitability

19.71%

About

Total Funding

$283.4M

Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses.

Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.

Number of employees

11-50

Headquarters

Boston, Massachusetts, United States

Meros Equity

2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.